InsiderTrades

Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.

Accepted 2024-07-12 00:00:00 ET · period of report 2024-07-10 · accession 0001601830-24-000103 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-07-12 2024-07-10+ RXRX Gibson Christopher CEO, Dir S - Sale $7.47 -100.0K 758.7K -12% -$747.5K
D 2024-07-12 2024-07-10 RXRX Gibson Christopher CEO, Dir G - Gift $0.00 -25.0K 758.7K -3% $0
DM 2024-07-12 2024-07-10+ RXRX Gibson Christopher CEO, Dir C - Cnv Deriv $0.00 +100.0K 808.7K +14% $0
DM 2024-07-12 2024-07-10+ RXRX Gibson Christopher CEO, Dir C - Cnv Deriv $0.00 -100.0K 6.23M -2% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-07-11 S D 50,000 $7.47 758,738 D — —
2 Common Class A Common Stock 2024-07-10 G D 25,000 $0.00 758,738 D — —
3 Common Class A Common Stock 2024-07-10 C A 50,000 $0.00 808,738 D — —
4 Common Class A Common Stock 2024-07-10 S D 50,000 $7.48 758,738 D — —
5 Common Class A Common Stock 2024-07-11 C A 50,000 $0.00 808,738 D — —
6 Derivative Class B Common Stock 2024-07-10 C D 50,000 $0.00 6,276,700 D $0.00 · — to — 50,000 Class A Common Stock (F3) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
7 Derivative Class B Common Stock 2024-07-11 C D 50,000 $0.00 6,226,700 D $0.00 · — to — 50,000 Class A Common Stock (F3) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.